Merck & Co., Inc. (LON:0QAH)
London flag London · Delayed Price · Currency is GBP · Price in USD
77.70
-0.25 (-0.32%)
At close: May 9, 2025
-40.37%
Market Cap 152.88B
Revenue (ttm) 49.47B
Net Income (ttm) 13.49B
Shares Out n/a
EPS (ttm) 5.32
PE Ratio 11.33
Forward PE 8.92
Dividend 2.45 (3.16%)
Ex-Dividend Date Mar 17, 2025
Volume 6,898
Average Volume 177,128
Open 77.70
Previous Close 77.95
Day's Range 76.44 - 78.38
52-Week Range 84.53 - 119.56
Beta 0.42
RSI 41.79
Earnings Date Apr 24, 2025

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janu... [Read more]

Sector Healthcare
Founded 1891
Employees 75,000
Stock Exchange London Stock Exchange
Ticker Symbol 0QAH
Full Company Profile

Financial Performance

In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.

Financial numbers in USD Financial Statements

News

There is no news available yet.